Eli Lilly And Company Net Income per Employee (LLY), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Eli Lilly And Company  (NYSE: LLY)
 

Eli Lilly And Net Income per Employee

LLY's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 25.34% in the second quarter 2026, year on year to cumulative value of $26,711 million, and with 50,000 employees, Eli Lilly And's income per employee grew on trailing twelve month basis to $ 534,224, this marks a new company high for all of 50,000 employees.
The Healthcare sector has seen employees of 28 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 321, from total ranking in previous quarter at 468.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LLY Net Income per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Net Income Change 25.34 % 168.04 % 50.52 % 475.34 % 90.78 %
Net Income per Employee (TTM) $ 534,224 505,534 412,800 368,242 275,998
LLY's Total Ranking # 321 # 468 # 379 # 431 # 485
Seq. Net Income Change -4.07 % 11.42 % 18.9 % -1.38 % 105.14 %

LLY Company Profile >> Back to LLY Efficiency Comparisons >> Compare LLY Net Income per Employee to its Competitors

LLY Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 29
Healthcare Sector # 47
Overall Market # 321

Net Income per Employee Statistics
High Average Low
$ 534,224 $ 99,944 $ -41,438
(Jun 30 2026)   (Dec. 31, 2008)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Protagenic Therapeutics Inc new  910,314.00 $ 5.462  Million 6 
Elite Pharmaceuticals Inc   871,814.86 $ 56.668  Million 65 
Krystal Biotech Inc   818,525.42 $ 241.465  Million 295 
The Greater Cannabis Company Inc   740,754.00 $ 0.741  Million 1 
Omeros Corporation  713,291.43 $ 124.826  Million 175 
Prestige Consumer Healthcare Inc   712,757.89 $ 406.272  Million 570 
Amgen Inc   672,538.46 $ 8,743.000  Million 13,000 
Atlantic Coastal Acquisition Corp Ii  670,333.33 $ 2.011  Million 3 
Illumina Inc   644,531.25 $ 825.000  Million 1,280 
Liquidia Corporation  641,694.44 $ 138.606  Million 216 
Harmony Biosciences Holdings inc   618,668.94 $ 181.270  Million 293 
Protagonist Therapeutics inc   616,272.73 $ 81.348  Million 132 
Theravance Biopharma inc   597,866.67 $ 53.808  Million 90 
Vaxart Inc   593,676.92 $ 38.589  Million 65 
Glucotrack Inc   554,600.00 $ 8.319  Million 15 
Eli Lilly And Company  534,224.00 $ 26,711.200  Million 50,000 
Silexion Therapeutics Corp  489,714.29 $ 6.856  Million 14 
Sanuwave Health Inc   488,872.73 $ 26.888  Million 55 
Acadia Pharmaceuticals Inc   476,796.99 $ 380.484  Million 798 
Biolife Solutions Inc   374,070.97 $ 57.981  Million 155 
Indivior Pharmaceuticals Inc   356,000.00 $ 356.000  Million 1,000 
Neurocrine Biosciences Inc   352,750.00 $ 705.500  Million 2,000 
Jazz Pharmaceuticals Plc  325,523.53 $ 940.763  Million 2,890 
Spero Therapeutics Inc   295,320.00 $ 7.383  Million 25 
Eton Pharmaceuticals Inc   288,363.64 $ 12.688  Million 44 


Date modified: 2026-09-12T18:39:21+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.